Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Why all women should freeze their eggs

Cobo, Ana; García-Velasco, Juan Antonio

Current Opinion in Obstetrics and Gynecology: June 2016 - Volume 28 - Issue 3 - p 206–210
doi: 10.1097/GCO.0000000000000269
FERTILITY, IVF AND REPRODUCTIVE GENETICS: Edited by Emre Seli and Juan Antonio García Velasco
Buy

Purpose of review The use of oocyte cryopreservation via vitrification has increased lately, becoming a common strategy in many IVF centers. This review summarizes the current state of oocyte vitrification, by analyzing the most recent reports on its use in IVF as part of infertile treatment and its contribution to elective fertility preservation (EFP).

Recent findings Oocyte vitrification has become helpful for managing different clinical situations currently providing similar results to fresh oocytes. Owing to satisfactory results, oocyte vitrification is being offered to healthy women to extend their reproductive options (EFP). Although little is known about outcomes in this specific population, new evidence is starting to emerge. Currently, most women are motivated by age and lack of partner. Age is strongly related to the probability of having a child with better chances when they do EFP younger than 35. In contrast to the biological efficiency, the majority of studies show that EFP is more cost-effective at 37–38 years.

Summary Oocyte vitrification is an efficient tool which can be helpful in managing the IVF cycle. Fertility preservation providers should inform women about their specific probabilities according to their age at vitrification, making emphasis in the fact that egg freezing does not guarantee success, but increases the possibilities of having a biological child in the future.

aInstituto Valenciano de Infertilidad (IVI), Valencia

bInstituto Valenciano de Infertilidad (IVI), Madrid, Spain

Correspondence to Ana Cobo, Instituto Valenciano de Infertilidad (IVI), Plaza de la Policia Local 3, 46015 Valencia, Spain. Tel: +34963050900; e-mail: ana.cobo@ivi.es

Copyright © 2016 YEAR Wolters Kluwer Health, Inc. All rights reserved.